Takeda Pharmaceutical Company Limited (TKDA.F) Stock Price, News & Chart

	TKDA.F	INDSWFTLAB.BO	MOREPENLAB.NS	STAR.BO	TEVA	4547.T
Market cap	61.66B	31.50B	53.21B	92.73B	48.81B	161.53B
P/E (TTM)	321.7	37.0	28.3	15.0	97.3	14.4
Forward P/E	33.3	—	—	11.7	13.4	17.6
Price/book	1.5	2.1	3.9	2.7	6.1	0.7
Dividend yield	2.91%	—	0.20%	0.49%	—	3.46%
1-year change	+59.48%	+239.52%	+112.26%	+8.29%	+70.37%	−6.36%
Today	+5.46%	−4.09%	−4.17%	−0.58%	−0.14%	+3.06%

Market cap

61.66B

31.50B

53.21B

92.73B

48.81B

161.53B

P/E (TTM)

321.7

37.0

28.3

15.0

97.3

14.4

Forward P/E

33.3

—

11.7

13.4

17.6

Price/book

1.5

2.1

3.9

2.7

6.1

0.7

Dividend yield

2.91%

—

0.20%

0.49%

—

3.46%

1-year change

+59.48%

+239.52%

+112.26%

+8.29%

+70.37%

−6.36%

Today

+5.46%

−4.09%

−4.17%

−0.58%

−0.14%

+3.06%

Company	Mkt cap	Price	Today
Ind-Swift Laboratories LimitedINDSWFTLAB.BO · Drug Manufacturers - Specialty & Generic	31.50B	356.45	−4.09%
Morepen Laboratories LimitedMOREPENLAB.NS · Drug Manufacturers - Specialty & Generic	53.21B	97.10	−4.17%
Strides Pharma Science LimitedSTAR.BO · Drug Manufacturers - Specialty & Generic	92.73B	1,006.00	−0.58%
Teva Pharmaceutical Industries LimitedTEVA · Drug Manufacturers - Specialty & Generic	48.81B	41.85	−0.14%
Kissei Pharmaceutical Co., Ltd.4547.T · Drug Manufacturers - Specialty & Generic	161.53B	3,870.00	+3.06%
Mochida Pharmaceutical Co., Ltd.4534.T · Drug Manufacturers - Specialty & Generic	119.24B	3,395.00	+3.66%
Windlas Biotech LimitedWINDLAS.NS · Drug Manufacturers - Specialty & Generic	19.01B	921.25	+5.47%
Solara Active Pharma Sciences LimitedSOLARA.NS · Drug Manufacturers - Specialty & Generic	31.04B	643.30	−0.25%

Company	Mkt cap	Price	Today
Yuyu Pharma, Inc.000220.KS · Jecheon-si, South Korea	58.66B	3,725.00	+0.40%
Sun Pharma Advanced Research Company LimitedSPARC.NS · Mumbai, India	63.66B	196.16	+5.84%
Suven Life Sciences LimitedSUVEN.BO · Hyderabad, India	63.96B	275.75	−0.14%
FDC LimitedFDC.BO · Mumbai, India	63.76B	391.65	+0.13%
Morepen Laboratories LimitedMOREPENLAB.NS · Gurugram, India	53.21B	97.10	−4.17%
H. Lundbeck A/S0ND5.IL · Valby, Denmark	55.36B	55.25	+0.45%
KYORIN Pharmaceutical Co., Ltd.4569.T · Tokyo, Japan	66.01B	1,149.00	+4.64%
Ildong Holdings Co., Ltd.000230.KS · Seoul, South Korea	65.20B	5,650.00	+0.89%

Company	Mkt cap	Price	Today
Align Technology, Inc.A1LG34.SA · Medical Instruments & Supplies	64.08B	225.50	+9.57%
Cardinal Health, Inc.CAH · Medical Distribution	60.65B	261.93	+3.55%
Merck KGaA1MRK.MI · Drug Manufacturers - Specialty & Generic	59.17B	136.10	+1.42%
Yuyu Pharma, Inc.000220.KS · Drug Manufacturers - Specialty & Generic	58.66B	3,725.00	+0.40%
Sun Pharma Advanced Research Company LimitedSPARC.NS · Drug Manufacturers - Specialty & Generic	63.66B	196.16	+5.84%
Natera, Inc.NTRA · Diagnostics & Research Odds	56.36B	391.03	+0.62%
Suven Life Sciences LimitedSUVEN.BO · Drug Manufacturers - Specialty & Generic	63.96B	275.75	−0.14%
CSL LimitedCSJ.F · Biotechnology	59.76B	124.54	+1.83%

Company	Mkt cap	Price	Today
Chugai Pharmaceutical Co., Ltd.CUP.F · Chuo, Japan	65.86B	40.02	+4.33%
Sumitomo Electric Industries, Ltd.SMO.F · Chuo, Japan	21.80B	6.99	−9.29%
Daiichi Sankyo Company, Limited4568.T · Chuo, Japan	5.61T	3,078.00	+5.79%
Bridgestone Corporation5108.T · Chuo, Japan	5.25T	4,256.00	+6.13%
Astellas Pharma Inc.4503.T · Chuo, Japan	4.79T	2,672.50	+6.88%
Mitsui Fudosan Co., Ltd.8801.T · Chuo, Japan	4.68T	1,737.50	+6.27%
SMC Corporation6273.T · Chuo, Japan	3.69T	59,130.00	−4.17%
Konami Group CorporationKNM.L · Chuo, Japan	3.89T	28,660.00	+19.37%

Company	Mkt cap	Price	Today
DAE HWA Pharmaceutical Co., Ltd.067080.KQ · life sciences	169.30B	9,190.00	−0.11%
Ipca Laboratories LimitedIPCALAB.NS · life sciences	494.62B	1,949.60	−1.14%
PharmaEssentia Corporation6446.TW · life sciences	490.25B	1,185.00	−5.20%
JW Pharmaceutical Corporation001060.KS · life sciences	531.36B	23,350.00	+1.08%
Glenmark Pharmaceuticals LimitedGLENMARK.NS · life sciences	700.43B	2,481.80	−0.91%
Aurobindo Pharma LimitedAUROPHARMA.NS · life sciences	1.03T	1,782.20	+4.53%
Gufic Biosciences LimitedGUFICBIO.BO · life sciences	43.65B	435.25	+2.03%
SAMSUNG PHARM. Co., LTD.001360.KS · life sciences	118.87B	1,263.00	+0.08%

Seeking Alpha·5d agoNegative

Takeda Pharmaceutical's Earnings Growth Has Yet To Translate To Higher Cash Flow

Takeda Pharmaceutical is reiterated as a hold, with concerns about its ability to replace major drug revenues and current valuation. Read more on TAK stock here. - Takeda Pharmaceutical is reiterated as a Hold, with concerns about its…

TAK BMY NVDA SPCX

The Globe and Mail·6d agoNegative

Bernstein Keeps Their Hold Rating on Takeda Pharmaceutical Co (TKPHF)

In a report released on January 16, Miki Sogi from Bernstein maintained a Hold rating on Takeda Pharmaceutical Co, with a price target of Yen4,700.00. The company’s shares closed last Tuesday at Yen5,073.00. Sogi covers the Healthcare…

USFD AZN JPM DB

MarketScreener·6d agoPositive

Takeda Pharmaceutical Raises Annual Guidance

Published on 10/29/2026 at 03:28 am EDT - Modified on 10/29/2026 at 03:29 am EDT Takeda Pharmaceutical raised its annual earnings forecasts, after swinging to a net profit in the second quarter. The Japanese drugmaker on Thursday reported…

LLY NVO TAK JNJ

Markets Daily·5d agoPositive

Takeda Pharmaceutical (NYSE:TAK) Posts Earnings Results, Beats Expectations By $0.37 EPS

Posted by Danessa Lincoln on Oct 30th, 2026 Takeda Pharmaceutical (NYSE:TAK – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.14 by…

TAK LLY BMY

MarketScreener·6d agoPositive

Takeda Pharmaceutical Eyes 2027 Japan Filing for Gastric Cancer Treatment

Takeda Pharmaceutical is targeting 2027 to file for regulatory approval in Japan for its experimental gastric cancer drug, arcotatug tavatecan, following positive results from a phase 3 clinical... Takeda Pharmaceutical Company Limited…

AZN

Seeking Alpha·6d ago

Takeda Pharmaceutical Company Limited 2026 Q2 - Results - Earnings Call Presentation

2026-10-30. The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction with their 2026 Q2 earnings call. The following slide deck was published by Takeda Pharmaceutical Company Limited in conjunction…

NVDA ABOS TAK PHAT

Seeking Alpha·Oct 29Positive

Takeda Pharmaceutical Non-GAAP EPS of ¥308.00, revenue of ¥2407B; upgrades FY 2026 outlook

Takeda Pharmaceutical reports 1H revenue up 8.4% year over year and non-GAAP EPS of ¥308. - Takeda Pharmaceutical press release (TAK): 1H Non-GAAP EPS of ¥308.00. - Adjusted Free Cash Flow was JPY 325.7 billion. - FY2026 full-year outlook…

GME TAK

Markets Daily·Oct 27Positive

Takeda Pharmaceutical (TAK) Expected to Announce Earnings on Thursday

Posted by Danessa Lincoln on Oct 27th, 2026 Check Out Our Latest Research Report on TAK Takeda’s portfolio includes treatments such as Entyvio for inflammatory bowel disease, Takhzyro for hereditary angioedema, and medicines for certain…

TAK LLY ALKS

24/7 Wall St.·Oct 15Positive

Takeda Pharmaceutical TAK Clears Its 52-Week High at $19.45

As seen on the 24/7 Wall St. homepage on October 15, 2026. Takeda Pharmaceutical touched $19.45, a fresh 52-week high that clears the September 17 peak by 2.1%. The ADR and the OTC line are both at the top of their range. Takeda…

TAK LLY JNJ PFE

Labroots·Oct 2

Takeda Pharmaceuticals' Psoriasis Pill Zasocitinib

Takeda Pharmaceuticals’ experimental psoriasis pill, zasocitinib, outperformed Bristol Myers Squibb’s Sotyktu in a phase 3 trial. Takeda purchased zasocitinib from Nimbus in 2022 for $4 billion ... Takeda Pharmaceuticals' Psoriasis Pill…

LLY NVS JNJ

Days on the list

30 d

1 yr

Best

Trending

—

Install

Takeda Pharmaceutical Company Limited

Key statistics

Against its peers

Latest news